News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Binax, Inc. Announces FDA 510k Clearance Of NOW Influenza A & B Rapid Test For Identification And Differentiation between Flu A And Flu B On One Simple Test


10/19/2005 5:11:59 PM

Binax, Inc., a leading developer of rapid diagnostic tests, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the NOW(R) Influenza A & B test. This latest test from Binax replaces two individual tests, NOW Flu A and NOW Flu B, and complements the company's portfolio of diagnostic tests for respiratory tract infections.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES